Inflammatory Demyelinating Polyneuropathy

• CLINICAL_TRIALS research · 2016-05-16
  Clinical Trial Update: sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN

  A clinical trial update investigates whether sCD163 and CD19 could serve as biomarkers for Chronic Inflammatory Demyelinating Polyneuropathy…

• CLINICAL_TRIALS research · 2016-05-12
  Clinical Trial Update: Effect of Resistance and Aerobic Exercise in CIDP or MMN [NA]

  A completed clinical trial evaluating the effects of resistance and aerobic exercise in chronic inflammatory demyelinating polyneuropathy an…

• CLINICAL_TRIALS trial_result · 2016-01-20
  Clinical Trial Update: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. [Phase 3]

  Phase III trial of NPB-01 as maintenance therapy for chronic inflammatory demyelinating polyneuropathy has completed.

• CLINICAL_TRIALS trial_result · 2015-09-22
  Clinical Trial Update: Immunoglobulin Dosage and Administration Form in CIDP and MMN

  A completed clinical trial update from Rigshospitalet evaluating immunoglobulin dosage and administration form for CIDP and MMN.

• CLINICAL_TRIALS trial_result · 2015-09-10
  Clinical Trial Update: Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 3]

  Phase 3 trial of intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy has completed and results have been posted…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2014-12-12
  Clinical Trial Update: Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

  This update describes a clinical trial examining changes in nerve conduction properties in IVIg-dependent neuropathies, including Guillain-B…

• CLINICAL_TRIALS trial_result · 2013-04-04
  Clinical Trial Update: Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy [Phase 3]

  A Phase 3 trial evaluating the efficacy and safety of Privigen in chronic inflammatory demyelinating polyneuropathy has completed, with resu…

• CLINICAL_TRIALS research · 2011-11-10
  Clinical Trial Update: Perception and Multisensory Integration in Neurological Patients Using fMRI [NA]

  An update on a brain-imaging clinical study investigating perception and multisensory integration in neurological patients using fMRI across…

• CLINICAL_TRIALS trial_result · 2011-11-10
  Clinical Trial Update: Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) [Phase 2]

  This document indicates the completion of a Phase 2 clinical trial assessing subcutaneous immunoglobulin treatment for chronic inflammatory …

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2]

  Phase 2 clinical trial evaluating intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy. The study has completed.

• CLINICAL_TRIALS trial_result · 2007-12-03
  Clinical Trial Update: Study of CIDP Patients During IVIG Treatment

  A completed clinical trial examining CIDP patients treated with intravenous immunoglobulin (IVIG).